Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -13.09% is 60% above its 5-year average of -32.63%, near the high end of its 5-year range (-89.18%–-3.47%).
As of the fiscal period ended Tuesday, June 30, 2026. 47.38% below its 12-month average of -8.89%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -13.09%.
RETURN ON INVESTED CAPITAL (ROIC)
-13.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-8.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-15.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-32.63%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-47.38%
CURRENT VS 3Y AVG
+15.13%
CURRENT VS 5Y AVG
+59.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.77%
median of 593 covered companies
CURRENT VS SECTOR MEDIAN
+62.34%
vs the sector median at left
Mirum Pharmaceuticals, Inc.
Market Cap
$4.82B
Return on Invested Capital (ROIC)
-13.09%
TTM Avg
-8.89%
3Y Avg
-15.43%
5Y Avg
-32.63%
Market Cap
$4.89B
Return on Invested Capital (ROIC)
-38.03%
TTM Avg
-36.93%
3Y Avg
-41.32%
5Y Avg
-48.18%
Market Cap
$4.73B
Return on Invested Capital (ROIC)
-18.48%
TTM Avg
-32.11%
3Y Avg
-33.07%
5Y Avg
-32.00%
Market Cap
$4.69B
Return on Invested Capital (ROIC)
6.39%
TTM Avg
-7.12%
3Y Avg
-17.71%
5Y Avg
-17.71%
Market Cap
$4.64B
Return on Invested Capital (ROIC)
3.03%
TTM Avg
-0.36%
3Y Avg
-5.28%
5Y Avg
-5.99%
Market Cap
$4.61B
Return on Invested Capital (ROIC)
-23.81%
TTM Avg
-42.00%
3Y Avg
-57.33%
5Y Avg
-55.42%
Market Cap
$5.04B
Return on Invested Capital (ROIC)
-90.04%
TTM Avg
-83.71%
3Y Avg
-67.61%
5Y Avg
-57.95%
Market Cap
$5.07B
Return on Invested Capital (ROIC)
5.80%
TTM Avg
5.65%
3Y Avg
5.40%
5Y Avg
4.23%
Market Cap
$5.09B
Return on Invested Capital (ROIC)
-50.09%
TTM Avg
-69.73%
3Y Avg
-67.26%
5Y Avg
-56.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.82B | -13.09% | -8.89% | -15.43% | -32.63% |
| Erasca, Inc. (ERAS)vs › | $4.89B | -38.03% | -36.93% | -41.32% | -48.18% |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.73B | -18.48% | -32.11% | -33.07% | -32.00% |
| BillionToOne, Inc. (BLLN)vs › | $4.69B | 6.39% | -7.12% | -17.71% | -17.71% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.64B | 3.03% | -0.36% | -5.28% | -5.99% |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.61B | -23.81% | -42.00% | -57.33% | -55.42% |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.04B | -90.04% | -83.71% | -67.61% | -57.95% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.07B | 5.80% | 5.65% | 5.40% | 4.23% |
| Cogent Biosciences, Inc. (COGT)vs › | $5.09B | -50.09% | -69.73% | -67.26% | -56.46% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | -6.67% | -24.96% | -29.08% | -26.21% |
ROIC
-13.1%
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -13.09% |
| 2026-03-31 | -11.34% |
| 2025-12-31 | -3.47% |
| 2025-09-30 | -6.69% |
| 2025-06-30 | -9.82% |
| 2025-03-31 | -13.56% |
| 2024-12-31 | -16.10% |
| 2024-09-30 | -17.38% |
| 2024-06-30 | -19.77% |
| 2024-03-31 | -19.87% |
| 2023-12-31 | -19.51% |
| 2023-09-30 | -19.22% |
| 2023-06-30 | -30.74% |
| 2023-03-31 | -44.13% |
| 2022-12-31 | -45.53% |
| 2022-09-30 | -45.58% |
| 2022-06-30 | -60.53% |
| 2022-03-31 | -65.08% |
| 2021-12-31 | -68.80% |
| 2021-09-30 | -89.18% |
| 2021-06-30 | -65.72% |
| 2021-03-31 | -69.37% |
| 2020-12-31 | -46.90% |
| 2020-09-30 | -69.88% |
| 2020-06-30 | -57.59% |
| 2020-03-31 | -44.33% |
| 2019-12-31 | -40.96% |
| 2019-09-30 | -27.40% |
| 2019-06-30 | -26.39% |
